proper Golgi stacks; instead, they cluster and fail to align properly (Acharya et al., 1995a) .
In both of the in vitro systems described above, NEM has similar effects. It causes defects in both the membrane fusion events that generate cisternae and in the process by which these cisternae form Golgi stacks. The fact that NEM can prevent stack formation in two different in vitro systems suggested that this was worthy of further investigation. Using the cell-free assay for mitotic disassembly and reassembly of the Golgi , we set out to identify the proteins on Golgi membranes that might mediate or establish the stacking of Golgi cisternae. Candidate proteins in this system should be NEM-sensitive proteins of Golgi membranes subject to some form of cell-cycle regulation, possibly by a cycle of direct phosphorylation and dephosphorylation as the cell enters and exits mitosis.
Results

Figure 1. Reassembly of Golgi Stacks In Vitro Requires NEM-and BMCC-Sensitive Factors
A Functional Approach to Identify Stacking Proteins
Disassembly assays were carried out using mitotic cytosol and rat It has been shown that when mitotic Golgi fragments liver Golgi membranes pretreated with NEM and quenched with (MGFs) are treated with NEM and supplemented with DTT. After incubation for 20 minutes at 37ЊC, the membranes were recovered and either left untreated (control) or treated with NEM or untreated cytosol, they can fuse in a cell-free system to BMCC followed by quenching with DTT. Reassembly assays were form cisternae, but these cisternae do not interact to then performed for 60 minutes at 37ЊC using control (B), NEM-(C), form Golgi stacks (Rabouille et al., 1995b) . It was also or BMCC-(D) treated membranes and interphase cytosol. Samples shown that if the starting Golgi membranes were treated of the starting stacked Golgi membrane (A) and the disassembly with NEM prior to disassembly with mitotic cytosol, they reaction (not shown) were kept on ice for analysis. Samples were disassembled and reassembled into Golgi stacks to the processed for electron microscopy, and the amount of cisternal membrane in structures containing either 1, 2, 3, or 4 cisternae was same extent as control membranes (Rabouille et al., quantitated. These values were normalized and the means plotted; 1995a). These observations implied that NEM-sensitive error bars indicate the SEM.
components associated with Golgi membranes were involved in the process by which cisternae form stacks, they could not be provided by cytosol, and they were present in Golgi stacks was then quantitated. When stacked Golgi membranes ( Figure 1A , RLG) with 2-3 not accessible to NEM on the starting Golgi membranes. We decided to utilize these observations to identify procisternae per stack were treated with NEM and disassembled with mitotic cytosol, a population of largely teins that might be involved in the establishment or maintenance of the stacked structure of the Golgi comsingle cisternae and tubular networks was generated (Misteli and Warren, 1994) . When supplemented with plex. Our strategy was to first block all accessible sulphydryl groups on the starting Golgi membranes with interphase cytosol, these membranes formed stacks of mainly two cisternae (Figure 1B, R60) . If the MGFs were NEM, then to treat these membranes with mitotic or interphase cytosols. In the case where mitotic cytosol alkylated with either NEM ( Figure 1C , NEM), or BMCC ( Figure 1D , BMCC) prior to addition of interphase cytowas used, previously inaccessible sulphydryl groups should be exposed, including those on proteins involved sol, they were unable to form stacks, greater than 80% of the cisternae being single. The differences observed in stacking of Golgi cisternae, and thus become substrates for NEM. Control reactions performed with inare not due to changes in the amount of membrane in reassembled cisternae. Little change in the amount of terphase cytosol should not yield the proteins of interest, since Golgi do not unstack under these conditions (MisGolgi membrane found in cisternae was observed when either control (38% Ϯ 3%), NEM-(34% Ϯ 6%), or BMCCteli and Warren, 1994) . To identify these proteins, we decided to use the reagent BMCC, which has the same (36% Ϯ 4%) treated membranes were used for the reassembly assay, consistent with previous observations specificity as NEM but is modified with a biotin tag and is thus easy to detect. It was first necessary to (see Table I in Rabouille et al., 1995a) . From these results it was concluded that BMCC, like NEM, is able to modify demonstrate that this reagent had the same properties as NEM, in being able to block the stacking of Golgi proteins required for the establishment of stacked Golgi cisternae. cisternae in the cell-free assay described above.
Golgi membranes were blocked with NEM, then treated with mitotic cytosol to generate a population of Purification of a Candidate Stacking Protein The next step was to identify the proteins modified by unstacked short cisternae and vesicles. These membranes were reisolated and either left untreated or alkyl-BMCC on MGFs. Golgi membranes were either left untreated or alkylated with NEM prior to incubation with ated with NEM or BMCC, followed by incubation with interphase cytosol to allow regrowth and stacking of either buffer, interphase, or mitotic cytosols. After recovery of the membranes, alkylation with BMCC was Golgi cisternae. The amount of cisternal membrane detailed in the Experimental Procedures. Briefly, the method was to extract the doped Golgi membranes with TX-100 and high salt-containing buffer on ice and to remove any insoluble material by centrifugation ( Figure  2B , lane 1). The cleared lysate was fractionated over a mono-Q column, and the peak fraction of p65 collected ( Figure 2B , lane 2). This was subsequently gel-filtered over a Superose 6 column, where the p65 fractionated as a protein of over 1000 kDa ( Figure 2B, lane 3) . Up to this point, both p65 and p130 had cofractionated. The Superose 6 pool was fractionated over a Biogel-HTP column, at which step p65 and p130 were separated; the peaks of both p65 ( Figure 2B , lane 4) and p130 ( Figure 2B , lane 5) are shown. The pool of p65 was then applied to a Q-Sepharose column, and the peak fraction of the eluate is shown ( Figure 2B , lane 6). Pure p65 had an estimated molecular size of 180 kDa by gel filtration on Superose 6 (not shown). The purification of p65, based on the ratio of the biotinylated p65 to total protein, was estimated to be 1,200-fold over starting Golgi membranes, and 70,000-fold over rat liver homogenate.
p65 Is a Conserved Protein
The purified 65 kDa protein band was excised from library from rat liver was screened using a fragment of (B) Purification of p65 was performed as described in the methods. Samples taken at every step of the purification were analyzed by the RACE clones as a probe. The sequences of the entire Figure 3A ). BLAST searches (Altschul et al., 1990) found lane 6). two positive matches similar throughout their lengths in the yeasts S. cerevisiae (30% identity) and S. pombe (40% identity), GenBank accession numbers U33057 performed and equal aliquots of each sample were analyzed by streptavidin overlay to detect the BMCC-modiand Z69239, respectively. Partial sequences present in the human and mouse EST databases were also found. fied proteins. In the absence of any NEM pretreatment of the starting Golgi membranes, many proteins were None of these sequences has any function ascribed to it or has any significant homology to any gene of known labeled by BMCC when either interphase ( Figure 2A , lane 1) or mitotic ( Figure 2A , lane 2) cytosols were used.
function. Comparison of the cloned rat sequence with the yeast sequences and a partial mouse EST reveals If the starting Golgi membranes were blocked with NEM, a completely different result was obtained. When buffer a highly conserved region of 100 amino acids (50%-60% similarity, 40% identity) containing a single conserved alone was used for the incubation, no proteins were found to be labeled by BMCC (Figure 2A, lane 3) . A cysteine residue corresponding to position 191 in the rat sequence ( Figure 3B ). This cysteine residue might single weakly labeled band was seen at 150 kDa when Golgi membranes were treated with interphase cytosol explain the sensitivity of the protein to the sulphydryl modifying agents NEM and BMCC. Inspection of the ( Figure 2A, lane 4) . In contrast, when mitotic cytosol was used, a major band of 65 kDa and two less intense bands sequence reveals no membrane-spanning domain, but a glycine was present at position two in a context that at 130 kDa and 160 kDa were seen ( Figure 2A , lane 5). These proteins specifically labeled by BMCC on MGFs means that it would be a good candidate for N-myristoylation (Johnson et al., 1994) , thus providing a way to were thus candidates for the NEM-sensitive Golgi stacking proteins.
anchor p65 directly to membranes. Since stacked Golgi membranes are present in all Focusing on p65, it was decided to scale up the production of biotinylated MGFs, then to add these to an nucleated mammalian cells, it was important to show that this gene was expressed in all tissues. Northern excess of untreated Golgi membranes. It was assumed that the nonbiotinylated and biotinylated forms of the blot analysis of a variety of rat tissues revealed that a 2.5 kb message, corresponding exactly to the size of the proteins would behave in the same way, allowing them to be followed through the subsequent purification as clone identified, is present in all of the tissues examined ( Figure 3C ). Interestingly, an additional second message of 1.5 kb is present in testis ( Figure 3C ).
To further verify that this was the correct clone for the biotinylated 65 kDa protein, in vitro transcriptiontranslation was performed. When analyzed by SDS- 
Membrane Protein
(B) Alignment of the conserved region of rat p65 with the S. cerevisTo investigate the properties of p65, specific antibodies iae and S. pombe homologs, and the partial mouse EST W75513. Identical (*) and conserved (.) residues are marked. The conserved were raised against amino acids 214-228 of the deduced cysteine residue is marked (ˆ).
sequence. These recognized a protein of 65 kDa in Golgi was absent from the cytosolic fraction ( Figure 4A , cytosol).
The orientation of p65 in Golgi membranes was probed using proteases, under conditions previously shown to result in the digestion of cytoplasmically oriented proteins and unstacking of Golgi cisternae (Cluett and Brown, 1992) . As controls, GM130, a cytoplasmically oriented peripheral membrane protein, and mannosidase II (Mann II), a lumenal protein, were used. Trypsin, chymotrypsin, or proteinase K treatment ( Figure 4B ) resulted in the total digestion of both p65 and GM130, whereas Mann II ( Figure 4B ) was unchanged. This observation shows that p65, like GM130, is oriented toward the cytoplasm. To find out how tightly p65 is associated with Golgi membranes, these were mock treated and washed with 10 mM EDTA, 1 M KCl, or 100 mM sodium carbonate (pH 11.0), the membranes pelleted, and the supernatants and pellets analyzed by Western blotting with specific antibodies. When an integral membrane protein such as Mann II was examined ( Figure 4B ), it was found in the pellet fraction under all conditions. A tightly associated peripheral membrane protein such as GM130 was found in the pellet, except when 100 mM sodium carbonate was used ( Figure 4B ). Under the same conditions, p65 was found to behave exactly as did GM130 ( Figure 4B ), implying that it is a tightly associated peripheral membrane protein. To confirm this observation, phase partitioning of Golgi membranes with TX-114 was performed, and equal aliquots of the aqueous phase, detergent phase, and insoluble pellet were analyzed by Western blotting. Again, it was found that p65 and GM130 behaved identically, both partitioning into the aqueous phase, while Mann II partitioned between both aqueous and detergent phases ( Figure 4B ). From these data, it was concluded that p65 is a tightly associated peripheral protein of Golgi membranes.
How then does p65 associate with Golgi membranes? Unlike GM130, which has no transmembrane domain or known lipid modifications that might explain its interaction with the membrane, p65 has a potential N-myristoylation site. To test if this site is actually used, the p65 control reaction ( Figure 4C, [Ϫ] ). This result shows that p65 is a substrate for N-myristoylation and might associate with membranes via its N-terminal myristic acid II ( Figure 5D ), or GalT ( Figure 5F ) revealed a considerable moiety.
overlap with these three Golgi markers. The degree of overlap was less with the TGN marker than the cisand medial/trans-Golgi markers, implying that p65 is Localization of p65 to the Golgi Complex To confirm that p65 is a Golgi protein, methanol-fixed localized more to the stacked regions of the Golgi complex. NRK cells were stained with rabbit polyclonal antibodies to p65 and monoclonal antibodies to either p115, a Transient transfection studies on Hela cells were carried out to provide further evidence that p65 is a protein marker of cis-Golgi, Mann II, a marker for medial/transGolgi, or ␤-1,4-galactosyltransferase (GalT) a marker for specifically present on Golgi membranes. Rat p65 was transfected into Hela cells, and after 24 hours, the cells the trans-Golgi and trans-Golgi network (TGN). It was not possible to perform double labeling with the polywere processed for immunofluorescence. The antibody used to detect p65 was made against a region of the clonal p65 and monoclonal GM130 antibodies, since the former only works in methanol-and the latter in protein not conserved from rat to human, and thus only recognized the transfected rat p65. At low levels of exparaformaldehyde-fixed cells. Labeling for p65 revealed a perinuclear, reticular staining pattern ( Figures 5A, 5C , pression, p65 was found to target only to the Golgi complex ( Figure 5G and 5I), as assessed by comparison and 5E) characteristic of the Golgi complex in these cells. Comparison of this with p115 ( Figure 5B ), Mann with the staining patterns of either p115 ( Figure 5H ) or 6A, GM130), both absent in the control lane ( Figure 6A , Con). These bands corresponded exactly with the 65 and 130 kDa biotinylated proteins found in total biotinylated MGFs. Thus, p65 is the major and GM130 one of the two minor proteins accessible to BMCC on MGFs. The IPs also reveal that biotinylated p65 ( Figure 6A , P65) and GM130 ( Figure 6A , GM130) co-IP from MGFs. These data suggested that p65 and GM130 form a complex in Golgi membranes under mitotic conditions. To find out if p65 and GM130 interact under interphase GalT ( Figure 5J) . It was not possible to use the antibody Mitotic Phosphorylation of p65 to Mann II in these experiments, since it is specific for One of the criteria in our original definition of candidate the rat protein. Analysis of p65 distribution by electron stacking proteins was that they should be subject to microscopy has been hampered by the low levels of some form of cell-cycle regulation. The most likely form antibody labeling caused by sensitivity to the aldehyde of regulation is direct phosphorylation during mitosis. To fixation necessary in sample preparation.
investigate this, standard disassembly reactions were These findings indicate that p65 is most likely to be performed with either interphase or mitotic cytosols in found on the cis and medial regions of the Golgi, rather the presence of [␥-32 P]ATP to label any phosphorylated than the more reticular TGN (Nilsson et al., 1993) , consisproteins. The membranes were recovered and subjected tent with its putative role in the establishment or mainteto IP with p65 or GM130 antibodies. IPs from mitotic nance of stacked Golgi cisternae.
incubations with p65 ( Figure 6C , P65) or GM130 ( Figure  6C , GM130) antibodies brought down a major phosphorp65 Exists in a Complex with GM130 ylated band at 65 kDa and a minor band of 130 kDa, both on Golgi Membranes absent from the control ( Figure 6C , Con), confirming that To prove that p65 was one of the proteins specifically p65 and GM130 are phosphorylated and still interact biotinylated in the MGFs, immunoprecipitations (IP) usunder these conditions. IPs from interphase incubations ing p65 antibodies were performed from these BMCCwith p65 ( Figure 6C Figure 6C , 6A, P65). During the purification of p65, it was noted MGF) with the p65 (Figure 6C , P65) and GM130 (Figure that the p130 copurified up to the biogel-HTP step and 6C, GM130) IPs revealed that these are among the major was only then separated from p65 ( Figure 2B, lanes 4 phosphoproteins. These observations support the view and 5). Microsequencing of the semipurified p130 that p65, as one of the major mitotic phosphoproteins, yielded two major peptides, FLAVSQNPADVPAPV and plays a key role in the structural changes seen in the AELQTALAHTQQAAR. These are perfect matches for Golgi during mitosis. rat GM130, a known component of a putative Golgi matrix also involved in the establishment of vesicle docking interactions (Nakamura et al., 1995 (Nakamura et al., , 1997 . To test for p65 Is Involved in Golgi Stacking an interaction between p65 and GM130, IPs with antiTo provide direct evidence that p65 is involved in the bodies to GM130 were performed from biotinylated mechanism by which Golgi cisternae come together to MGFs. When analyzed by streptavidin overlay, proteins of 130 kDa and 65 kDa were visible in GM130 IPs ( Figure  form ordered stacks, we decided to test the effects of anti-p65 antibody blocked with the peptide against which it was raised, or the recombinant His-tagged p65, followed by incubation with interphase cytosol to allow the regrowth and stacking of cisternae. Reassembly of control MGFs ( Figure 7A , R60) gave rise to Golgi stacks with 2-3 cisternae per stack, as expected. When the MGFs were preincubated with the anti-p65 antibody or an excess of the recombinant p65 protein, a different result was obtained. In these cases ( Figure 7B , antip65; Figure 7D , His-P65), Golgi stacks were not formed; rather, a population of single cisternae and vesicles were observed similar to those seen with NEM or BMCC treatment. When the anti-p65 antibody was preincubated with the peptide against which it was raised, reassembly occurred as in the control incubation, stacks of 2-3 Golgi cisternae being generated ( Figure 7C , anti-p65). These differences are not due to changes in the amount of membrane in reassembled cisternae, as this was not significantly changed when either control (34% Ϯ 6%), anti-p65 (31% Ϯ 2%), anti-p65 plus peptide (36% Ϯ 5%), or His-tagged p65 (29% Ϯ 2%) treated membranes were used for the reassembly assay.
From these results, we concluded that recombinant p65 and antibodies to p65 act to specifically block the formation of Golgi stacks but not the formation of cisternae in the cell-free system for Golgi reassembly. This provides strong evidence that p65 is a key component of the mechanism giving rise to the stacked cisternal structure of the Golgi complex.
Discussion
We have exploited the NEM sensitivity of the cell-free system for disassembly and reassembly of the Golgi complex to identify proteins involved in establishing its stacked cisternal structure. Using this system, we identified one major and one minor protein. The major protein was p65, and the minor protein was GM130, a vesicle docking receptor and component of a putative Golgi Figure 7 . Stacking of Golgi Cisternae Is Blocked by Antibodies to matrix (Nakamura et al., 1995 (Nakamura et al., , 1997 . Several lines of p65 and a Recombinant Form of p65 evidence point to the involvement of p65 in Golgi stackDisassembly assays were carried out using mitotic cytosol and rat ing: (1) it is a tightly bound peripheral protein that is liver Golgi membranes for 30 minutes at 37ЊC. The membranes were recovered and treated for 15 minutes on ice with either buffer (A), restricted to Golgi membranes; (2) it is modified in a cell 2.0 g of affinity purified anti-p65 antibody (B), the same antibody cycle-regulated manner, and during mitosis it is a major, that had been preincubated with 2.0 g of the peptide against which if not the major, phosphorylated Golgi protein; (3) when it was raised (C), or 1.0 g of recombinant His-tagged p65 (D).
added to the Golgi reassembly assay, antibodies to the Reassembly assays were then performed for 60 minutes using these native protein blocked the stacking but not the regrowth membranes and interphase cytosol at 37ЊC. Samples were proof cisternae; (4) similar results were obtained adding an cessed for electron microscopy, and the amount of cisternal membrane in structures containing either 1, 2, 3, or 4 cisternae quantiexcess of a soluble recombinant form of p65 lacking tated. These values were normalized and the means plotted; error the N-terminal myristic acid; and (5) p65 nation of p65 as a Golgi ReAssembly Stacking Protein (GRASP65). p65-specific reagents in the cell-free system for Golgi reassembly. For this purpose, we chose to use an anti-A Protein Complex Involved in Golgi Stacking body to p65 (FBA21.1) that recognizes the protein under GRASP65 interacts with GM130 to form a stable comnative conditions, for example in native IPs ( Figure 6B , plex that is not disrupted under either interphase or P65), and a recombinant His-tagged form of the protein mitotic conditions. It is known that GM130 in detergent purified from bacteria.
extracts of Golgi membranes, like GRASP65, gel-filters Disassembly of stacked Golgi membranes was perat about 1.2 MDa, implying that it is in a large oligomeric formed with mitotic cytosol to give rise to a population structure (Nakamura et al., 1995). These observations of unstacked short cisternae and vesicles. These membranes were treated with either anti-p65 antibody, the indicate that GRASP65 and GM130 are part of a large complex containing other Golgi proteins. One protein in addition to its myristic acid anchor, or it interacts with a protein that has one. that interacts with the GM130 component of this complex is already known (Nakamura et al., 1997) . It is p115, a protein associated with early events in vesicle docking Regulation of Golgi Structure by GRASP65 prior to the action of NSF (Sapperstein et al., 1996) .
The process of stacking can be viewed as a specialized GM130 binds to p115 in a cell cycle-regulated manner form of docking event, that of one cisterna with another. and is thought to be involved in the disruption of the This docking event, unlike that which occurs when a Golgi in mitosis, when continued vesicle budding in the vesicle interacts with its target membrane, would not absence of fusion is thought to lead to its fragmentation result in fusion of the two membranes but rather in a and subsequently, in the membrane fusion reactions stable interaction. This interaction could be regulated required for the regrowth of cisternae during Golgi reasby phosphorylation, since GRASP65, like GM130, is a sembly (Nakamura et al., 1997). These observations do substrate for mitotically active protein kinases. Thus, not exclude a role for GM130 with GRASP65 in stacking.
phosphorylation may regulate two different but possibly While p115 (Sapperstein et al., 1995) and GRASP65 have linked functions associated with the GRASP65-GM130 homologs in yeast, no homolog of GM130 has yet been complex: (1) vesicle docking via p115-GM130 interacdescribed. This might indicate that vesicle docking and tions, and (2) stacking via interactions of GRASP65 with cisternal stacking are regulated differently in yeast and as yet unknown proteins. It is not yet clear if the complex mammals but share some of the same components, containing GRASP65 and GM130 is required for the essuch as p115/Uso1p and GRASP65, respectively. tablishment of the interactions occurring between stacked cisternae, in their maintenance, or in both of these processes. A parallel could be drawn with the nerve termi-NEM Sensitivity of the GRASP65-GM130 Complex nus, where the vesicle docking event with the plasma There are two possibilities that could explain how the membrane found in all cells has been modified by the modification of the GRASP65-GM130 complex in MGFs presence of accessory subunits, exemplified by the synby NEM or BMCC might block stacking in the cell-free aptotagmin family of proteins, to allow regulation by assay. One is that modification by these reagents inacticalcium. Synaptotagmins bind to components of the vates an enzymatic activity required for Golgi stack forexocytic machinery, the SNAREs, and exert an inhibitory mation, in a similar fashion to the NEM inhibition of effect on membrane fusion (Schiavo et al., 1995) . Binding vesicle fusion where NSF is the target (Block et al., 1988) .
of calcium to synaptotagmin triggers the release of this The other is steric hindrance due to modification of a inhibitory action and allows the docked synaptic vesicle cysteine residue in some key region of the target protein to fuse with the presynaptic membrane. Thus, GRASP65, required for interaction with another protein. An example possibly in conjunction with GM130 and p115, could act of this is in the NEM inhibition of n-sec1 binding to to modulate docking interactions between Golgi cistersyntaxin 1A (Meffert et al., 1996) . Given that neither nae, with phosphorylation rather than calcium binding GRASP65 nor GM130 have homology to any known enbeing the regulatory trigger. During mitosis, phosphoryzyme, it is more likely that NEM and BMCC are acting lation of GRASP65 and GM130 could lead to disruption by steric hindrance, preventing the reassociation of of these interactions, allowing the unstacking and subthe GRASP65-GM130 complex with other proteins, or sequent fragmentation of the Golgi complex. changes in its oligomeric state after mitosis. segments or known covalent modifications, such as in water, were stored at Ϫ20ЊC. Antibodies were as follows: NN5-1 rabbit polyclonal and monoclonal 2C10 to GM130; monoclonal fatty-acylation, that could mediate its interaction with 53FC3 to Mann II; monoclonal GTL2 to GalT; and monoclonal 4H1 membranes (Nakamura et al., 1995) . Since GM130 and to p115.
GRASP65 are tightly associated in a complex on the surface of Golgi membranes that is not disrupted in Cell-Free Incubations mitosis, it is possible that one of the functions of Disassembly and reassembly assays were carried out using Hela GRASP65 is to target GM130 to Golgi membranes. The N cytosols and purified rat liver Golgi membranes (Rabouille et al., terminus of GRASP65 is N-myristoylated, a modification 1995a). Golgi membranes were treated on ice with 2.5 mM NEM or 0.34 mM BMCC for 15 minutes followed by quenching with 5 mM known to be sufficient for the targeting of some proteins DTT for 10 minutes. After incubations with cytosol, Golgi membranes to membranes (Johnson et al., 1994) . Although N-myriswere recovered by centrifugation through a 1 ml cushion of 0.5 M toylation can form an essential component of a Golgi sucrose in 100 mM potassium phosphate (pH 6.7) at 55 Krpm for targeting signal, for example in epithelial nitric oxide 20 minutes at 4ЊC in the TLS55 rotor.
synthase (Liu et al., 1996) , alone it is not specific for
To prepare 32 P-labeled Golgi membranes, standard 50 l disasGolgi membranes (Johnson et al., 1994) . This implies sembly reactions were performed using interphase or mitotic cytosols with the addition of 100 Ci of [␥-32 P]ATP (160 mCi/ml, ICN that either GRASP65 possesses a Golgi targeting signal Pharmaceuticals Inc.). The 32 P-labeled membranes were recovered collecting 1 ml fractions. Peak fractions of p65 were pooled (2 ml) and subjected to chloroform-methanol precipitation to remove the as above for further analysis.
TX-100. The pellet was solubilized in 200 l of sample buffer, subjected to SDS-PAGE, and the band corresponding to 50-75 g p65 Electron Microscopy and Stereology (BSA as standard) excised from the Coomassie-stained gel. The Standard techniques for the fixation, processing, sectioning, and peak fractions of p130 from the Biogel-HTP column were subjected staining of samples were used (Misteli and Warren, 1994) . Stereologto methanol-chloroform precipitation and fractionated by SDSical definitions and methods were as defined previously (Misteli and PAGE as for p65, and the well-resolved band in this region was Warren, 1994) and were briefly as follows. Cisternae were membrane excised. profiles with a length more than four times their width, which was not greater than 80 nm. Stacks were two or more cisternal profiles separated by a gap of no more than 15 nm, overlapping by greater Protein Microsequencing than half their length. Stacks were subdivided into categories based Bands excised from multiple gels were combined and reconcenon the number of cisternae in the stack. The relative proportion of trated in a secondary gel (Gevaert et al., 1996) . The concentrated each category of membrane was determined by counting the numprotein was digested in-gel with 1.0 g of trypsin in 20 l of 0.1 M ber of intersections of each membrane structure with a 4 mm line Tris-HCl (pH 8.6), 1 mM CaCl 2 for 8 hours at 37ЊC. After digestion, grid. From these values, the relative amount of stacked cisternal the supernatant was removed and placed in a clean tube. The gel membrane and the distribution of this membrane in stacks of n slice was extracted for 20 minutes with 60% acetonitrile in 0.1% cisternae were calculated. trifluoroacetic acid (TFA), combined with the supernatant, and dried down. This residue was dissolved in 200 l of 0.1% TFA, injected SDS-PAGE and Western Blotting on a C-18 RP-HPLC column (2.1 mm ϫ 250 mm; Vydac Separations Protein samples were solubilized in SDS-PAGE sample buffer, Group, Hesperia, CA) that was eluted with a linear gradient of acetoboiled for 3 minutes, and analyzed on SDS-polyacrylamide gels.
nitrile in 0.1% TFA. The eluate was split: 80% into a UV absorbance Western blotting was performed using a semidry blotter on nitroceldetector and 20% into a Fisons/VG Platform (Manchester, UK) mass lulose. Blocking and antibody incubations were performed in PBS spectrometer. Peptides absorbing at 214 nm were collected, and plus 10% (w/v) low-fat skim-milk powder. All secondary antibodies those corresponding to single peptide masses were selected for or streptavidin were HRP conjugates (Tago, Buckingham, UK) deautomated Edman degradation. tected using ECL (Amersham Life Science, UK).
Cloning
Purification of p65
Nested primers designed from the rat EST sequence were: FM1, Golgi membranes were prepared (Nakamura et al., 1995) from the GCTAGGGGCAAGCAGCGAGCACGTGTGGC; FM3, GCTGGATGTG livers of 48 male Sprague-Dawley rats; when pooled, these yielded GAGCCCTCTTCACCCGCTG; FM2, GCCAAGGTGTGGGGCACCAA 70 mg of membrane protein, at 4.7 mg/ml, purified 130-fold over GAGGAAAGGC; and FM6, GCATTAGGTTGTGGGGTCTTAGCTGGA the homogenate as judged by the specific activity of GalT. All of the GTGCC. Nested RACE reactions with a rat liver cDNA pool as the following steps were performed at 4ЊC. The sucrose concentration of target and pfu polymerase (Stratagene, UK) were performed with the pooled Golgi membranes was adjusted to 0.25 M by addition adaptor primers AP1 and AP2 from the Marathon cDNA kit (Clontech, of PA (100 mM potassium phosphate buffer [pH 6.7] ) to give 34 ml, CA) with either primers FM1 and FM3, or FM2 and FM6 for 3Ј and followed by the addition of 11.3 ml of 4 M KCl. After 10 minutes on 5Ј RACE, respectively. Overlapping RACE clones were fused at a ice, the membranes were pelleted by centrifugation at 10 Krpm for unique KpnI site to generate a full-length cDNA in the EcoRV site 30 minutes at 4ЊC in the Beckman SW28 rotor. The supernatant of pBluescript II (pBSII, Stratagene, UK). To confirm that the RACE was discarded and the membranes resuspended in 10 ml of PA clones were correct, a 1.5 kb SmaI fragment from the predicted containing 0.25 M sucrose. Biotinylated MGFs prepared from 1.0 open reading frame was used to screen a rat liver cDNA library in mg of Golgi membranes were mixed with the washed membranes gt11 (RL5001b, Clontech, CA). Screening of 1.5 million plaques at and pelleted as above, and then the pellet was resuspended in 10 ml medium stringency resulted in the identification of eight positive of PA containing 1% (w/v) TX-100, 1 M KCl, and protease inhibitors (2 clones. The inserts from these phage were subcloned into the EcoRI g/ml aprotinin, 100 M chymostatin, 10 M leupeptin, 1 M pepsite of pBSII for restriction mapping and sequencing. statin A, 0.5 mM 1,10-phenanthroline, 0.25 mM PMSF, 1 mM EDTA). After 10 minutes, the detergent extract was diluted to 100 ml with PA containing 1% (w/v) TX-100 and centrifuged at 2000 g for 10
Northern Blotting minutes to pellet any insoluble material. The cleared extract (50 ml A multiple rat tissue Northern blot (Clontech, CA) with approximately aliquots) was loaded on a mono-Q HR5/5 column equilibrated with 2.0 g of poly(A) ϩ RNA from the tissues indicated in the appropriate Q100 (25 mM Tris-HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100).
figure legend, was hybridized with a random-primed 1.5 kb SmaI After washing with 10 ml of Q100, the column was eluted with a 40 fragment of the p65 clone. After hybridization, the filter was washed ml linear gradient of Q100 to Q1000 (25 mM Tris-HCl [pH 7.4], 1000 at medium stringency then exposed to film. mM KCl, 1% [w/v] TX-100) collecting 1 ml fractions. Aliquots of each fraction were analyzed by streptavidin overlay to detect biotinylated In Vitro Transcription-Translation proteins. Fractions from 300-350 mM KCl containing the peak of In vitro transcription-translation reactions (Promega) of 50 l were p65 and p130 were pooled, then loaded (1 ml aliquots) on a Superose performed with the T7 polymerase for 2 hours at 30ЊC using 0.5 g 6 HR10/30 column equilibrated with Q1000, and 1 ml fractions were of plasmid DNA and methionine minus amino acid mix plus 4 l then collected. Peak fractions of p65 and p130, gel-filtering at an of [
35 S]L-methionine (typically 1400 Ci/mmol and 11 mCi/ml, ICN approximate molecular weight of 1.2 MDa, were pooled (8 ml), diPharmaceuticals Inc.) or total amino acid mix plus 0.5 l of [ 3 H]myrisluted to 40 ml of Q0 (25 mM Tris-HCl [pH 7.4], 1% [w/v] TX-100), tic acid (typically 40-60 Ci/mmol and 1 mCi/ml, Amersham Life Sciand adjusted to 5 mM potassium phosphate (pH 7.4). This was ence, UK). loaded on a 5 ml Biogel-HTP column equilibrated with HTP5 (25 mM Tris-HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100, 5 mM potassium phosphate). After washing with 10 ml of HTP5, the column was Immunoprecipitations Immunoprecipitations were performed in IP buffer (20 mM HEPESeluted with a 20 ml linear gradient of HTP5 to HTP200 (25 mM Tris-HCl [pH 7.4], 100 mM KCl, 1% [w/v] TX-100, 200 mM potassium KOH [pH 7.3], 200 mM KCl, 0.5 % [w/v] TX-100) using 5 l of the appropriate antiserum and either 10 l of packed protein A-or phosphate) collecting 1 ml fractions. At this step p65 was separated from p130, and they eluted with peaks at 75 mM and 125 mM protein G-Sepharose (Pharmacia) for rabbit polyclonal and mouse monoclonal antibodies, respectively. After binding for 60 minutes phosphate, respectively. Peak fractions of p65 were pooled (3 ml) and diluted to 15 ml in Q0 prior to loading on a 1 ml Q-Sepharose at 4ЊC, the beads were washed four times with 500 l of IP buffer and eluted with 30 l of SDS-PAGE sample buffer, and the eluate column equilibrated in Q100. After washing with 10 ml of Q100, the column was eluted with a 20 ml linear gradient of Q100 to Q1000, was analyzed as appropriate. (1996) . vitrogen). Hela cells were plated at 10% density in 2-cm wells conNitric oxide modulates synaptic vesicle docking fusion reactions. taining a glass coverslip and left to attach for 12 hours. Transfection
Immunofluorescence Microscopy
Neuron 16, 1229-1236. of 2.5 g of plasmid DNA per well was performed using the calcium Misteli, T., and Warren, G. (1994) . COP-coated vesicles are involved phosphate precipitation method (Nilsson et al., 1993 
